Dr. Ted Fjällman Fjallman is the CEO of Prokarium, a London-based biotech developing microbial immunotherapy and vaccines.

e-Meet Ted at #Sachs_BEF

More info @ https://t.co/XI3zEYGyl2 pic.twitter.com/8Leoa6OEFR

— Sachs Associates (@SachsAssociates) September 8, 2020